QCLS - MyMD Pharmaceuticals, Inc.
4.5
1.020 22.667%
Share volume: 10,947,143
Last Updated: 03-06-2026
Pharmaceutical Products/In Vitro, In Vivo Diagnostic Substances:
-0.03%
PREVIOUS CLOSE
CHG
CHG%
$3.48
1.02
0.29%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 05-15-2024 | 08-19-2024 | 11-14-2024 | 05-15-2025 | 08-19-2025 | 11-19-2025 | |
| Assets | |||||||
| Total Assets | 14.494 M | 26.382 M | 24.044 M | 18.781 M | 17.151 M | 37.232 M | |
| Current Assets | 2.460 M | 14.358 M | 12.027 M | 6.779 M | 5.153 M | 11.146 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 2.482 K | 0.000 | 0.000 | |
| Short Term Investments | 1.509 M | 14.030 M | 10.949 M | 5.805 M | 3.606 M | 3.092 M | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 225.655 K | 536.026 K | 1.192 M | 73.244 K | 207.553 K | 6.904 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Assets | 12.033 M | 10.524 M | 10.517 M | 12.001 M | 11.999 M | 26.086 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||
| Total Liabilities and shareholders’ equity | 14.494 M | 26.382 M | 24.044 M | 18.781 M | 17.151 M | 37.232 M | |
| Total liabilities | 4.253 M | 26.000 M | 6.989 M | 4.939 M | 5.550 M | 15.914 M | |
| Total current liabilities | 3.973 M | 5.783 M | 6.989 M | 4.939 M | 5.550 M | 6.534 M | |
| Accounts Payable | 3.861 M | 4.617 M | 4.160 M | 2.594 M | 2.677 M | 3.181 M | |
| Other liabilities | 279.615 K | 0.000 | 0.000 | 0.000 | 0.000 | 9.380 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 279.615 K | 0.000 | 0.000 | 0.000 | 0.000 | 9.380 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 9.793 M | -46.719 K | 16.633 M | 8.546 M | 5.133 M | 14.176 M | |
| Common stock | 122.772 M | 123.275 M | 142.635 M | 139.623 M | 138.982 M | 151.738 M | |
| Retained earnings | -112.979 M | -123.322 M | -126.002 M | -131.077 M | -133.849 M | -137.562 M |